The Recall Desk
SevereFDA (Devices)·Z-2027-2023·Announced 2023-07-12

FDA Recalls TruSignal AllFit Oximeter Sensors Worldwide for Device Malfunction

GE Healthcare is recalling 36,337 TruSignal AllFit Sensor oximeters worldwide due to potential defibrillation energy loss, voltage exposure, and measurement errors.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I recall as classified by the agency, which indicates a serious device malfunction that may cause harm. Although no illnesses or injuries have been reported, the potential for defibrillation energy loss and unintended voltage exposure creates significant patient risk.

Plain-English summary

GE Healthcare Finland Oy is recalling 36,337 TruSignal AllFit Sensor oximeters (models REF TS-AF-10 and REF AF-25) distributed worldwide. The FDA has classified this as a Class I recall.

The sensors may experience potential reduction of energy reaching the patient during defibrillation, potential contact with unintended voltage, or provide inaccurate measurements. These defects may affect patient safety during cardiac monitoring and treatment.

No illnesses or injuries have been reported. If you are using affected devices, contact your healthcare provider or GE Healthcare for replacement or return instructions.

The recalled product

Product
TruSignal AllFit Sensor: a) REF TS-AF-10, 10 pcs; B) REF AF-25, 25 pcs; Oximeter
Manufacturer
GE Healthcare Finland Oy
Hazard
  • defibrillation-failure
  • electrical-hazard
  • measurement-error

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • a) REF TS-AF-10
  • GTIN 0840682103176 b) REF TS-AF-25
  • GTIN 0840682103176

Distribution

Distribution scope not specified by the agency.